# FDA Inspection 1260148 - Nicolas Leitz, M.D. - December 13, 2024

Source: https://www.keypedia.com/records/fda_inspections/nicolas-leitz-md/47e9060f-40ba-49e2-90bf-5471d56d85d7
Source feed: FDA_Inspections

> FDA Inspection 1260148 for Nicolas Leitz, M.D. on December 13, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1260148
- Company Name: Nicolas Leitz, M.D.
- Inspection Date: 2024-12-13
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1260148 - 2024-12-13](https://www.keypedia.com/records/fda_inspections/nicolas-leitz-md/3968bd59-5ee4-4b95-b492-7f2e72bf6f50)

Company: https://www.keypedia.com/companies/nicolas-leitz-md/376faeb8-9ac0-4b4c-86b7-9352f23c9cca

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c